Purchase Order 12305B20P0165

This is a $5,820 firm-fixed price purchase order awarded by the National Institutes of Health (NIH) to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for monoclonal antibody production services. The contract is not set-aside and was awarded under the NIH's Acquisition Operations. Precision Antibody is a for-profit manufacturer of specialized biological materials and services, including custom antibody development, cell lines, and peptide synthesis, in support of biomedical...

The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a $38,454 firm-fixed price contract to Bio-Rad AbD Serotec GmbH, a subsidiary of Bio-Rad Laboratories, Inc., to provide lab testing services for custom monoclonal recombinant antibodies generated through HuCAL technology. The contract will support the generation of monoclonal recombinant antibodies that the NIAID lab will use for in-vitro...

This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), to Pacific Immunology, a USA-based biotech company located in Ramona, California. The contract is for the production of monospecific antibodies, with a ceiling value of $4,321.60 and an ultimate completion date of March 10, 2010. The contract does not utilize a set-aside designation. Pacific Immunology, the prime...

This federal contract award to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, is for the delivery of custom rabbit monoclonal antibodies to support the development of diagnostic tests for taeniasis and cysticercosis. The award, valued at $49,981.00, was made by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia and has a period of performance from September 30, 2024 to April 22, 2025. The original solicitation, a Request for Quotations (RFQ), was...

This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $3,800.00, is for custom monoclonal antibody production services to support NIAID's biomedical research and public health initiatives. This contract does not have a set-aside designation. Genscript...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $33,560 purchase order to Antibodies Incorporated for two monoclonal antibody projects. Antibodies Incorporated, doing business as Antibodies Inc., will deliver the requested monoclonal antibodies from its Bethesda, Maryland facility within the one-month period of performance ending September 30, 2023. As the prime contractor, Antibodies Inc. will be responsible for completion of the two...

The U.S. Department of Health and Human Services, National Institutes of Health, National Center for Advancing Translational Sciences awarded a firm-fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to generate drug-specific monoclonal antibodies against TTHX1114, an engineered mutant human FGF1. The $50,208.55 contract has a completion date of June 30, 2020 and does not have a set-aside designation. Precision Antibody is a for-profit...

This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...

This is a $97,722.00 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support NIAID's research initiatives, with a completion date of September 19, 2025. This contract is not designated as a set-aside....

This contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, provides Genscript USA Inc. with $137,250.00 to deliver monoclonal antibodies and plasmid services. The firm-fixed price purchase order has an ultimate completion date of August 31, 2025. Genscript USA Inc. is a biotechnology company in Piscataway, New Jersey that specializes in molecular biology products and services for federal agencies....